Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
The current price of EKSO.BOATS is $10.86 USD — it has increased by +3.13% in the past 24 hours. Watch Ekso Bionics stock price performance more closely on the chart.
What is Ekso Bionics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ekso Bionics stocks are traded under the ticker EKSO.BOATS.
What is Ekso Bionics market cap?▼
Today Ekso Bionics has the market capitalization of 28.49M
When is the next Ekso Bionics earnings date?▼
Ekso Bionics is going to release the next earnings report on April 23, 2026.
What is Ekso Bionics revenue for the last year?▼
Ekso Bionics revenue for the last year amounts to 35.85M USD.
What is Ekso Bionics net income for the last year?▼
EKSO.BOATS net income for the last year is -22.66M USD.